当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第26期
编号:13406879
线粒体DNA D-LOOP区点突变和长期慢性肝炎、肝癌的相关性分析(4)
http://www.100md.com 2019年9月15日 《中国医药导报》 2019年第26期
     [14] Li S,Wan P,Peng T,et al. Associations between sequence variations in the mitochondrial DNA D-loop region and outcome of hepatocellular carcinoma [J]. Oncol Lett,2016,11(6):3723-3728.

    [15] Yin C,Cao HY,Chen YB,et al. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis [J]. Ann Oncol,2019,30(6):953-962.

    [16] Chen T,Xun Z,Lin J,et al. Association between mitochondrial DNA content and baseline serum levels of HBsAg in chronic hepatitis B infection [J]. J Med Virol,2017,89(11):1958-1962.

    [17] Li L,Hann HW,Wan S,et al. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection [J]. Sci Rep,2016,6(1):23 992.

    [18] Campo DS,Nayak V,Srinivasamoorthy G,et al. Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma [J]. BMC Med Genomics,2019,12(4):74.

    [19] Guo ZS,Jin CL,Yao ZJ,et al. Analysis of the Mitochondrial 4977 Bp Deletion in Patients with Hepatocellular Carcinoma [J]. Balkan J Med Genet,2017,20(1):81-86.

    [20] Gao Y,Nie HJ,Yang D,et al. Changes of the mitochondrial DNA copy number and the antioxidant system in the PBMC of hepatocellular carcinoma [J]. Zhongguo Ying Yong Sheng Li Xue Za Zhi,2016,32(1):1-5.

    (收稿日期:2018-06-05 本文編辑:任 念), 百拇医药(柳云 刘道洁 乔录新 陈德喜)
上一页1 2 3 4